Form 4: Bolt Biotherapeutics CEO Acquires Shares and Stock Options

William P. Quinn, CEO of Bolt Biotherapeutics, reports acquiring common stock and stock options through an employee stock purchase plan and option grant.

Summary

• On December 16, 2024, William P. Quinn acquired 2,500 shares of Bolt Biotherapeutics common stock at $0.4965 per share.
• On June 6, 2024, Quinn acquired 2,500 shares of common stock at $0.6374 per share.
• As of the report, Quinn directly owns 41,272 shares of common stock.
• Quinn was also granted options to purchase 700,000 shares of common stock at an exercise price of $0.351 on May 1, 2025.
• The options vest monthly over three years, starting January 1, 2025, contingent upon continuous service to the Issuer, and expire on April 30, 2035.

Sentiment

Score: 7

Explanation: The document reflects standard insider trading activity, with the CEO increasing their stake in the company through stock purchases and option grants, which is generally a positive signal.

Positives

• The CEO's acquisition of shares through the employee stock purchase plan demonstrates confidence in the company.
• The grant of stock options incentivizes the CEO to drive long-term value for the company.

Future Outlook

The vesting of stock options is contingent upon the Reporting Person continuously providing services to the Issuer.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Stock option grants and employee stock purchase plans are common compensation practices in the biotechnology industry to align management's interests with those of shareholders.
• The vesting schedule of the options (monthly over three years) is a typical structure to incentivize long-term commitment.

Stakeholder Impact

• Shareholders may view the CEO's stock purchases and option grants as a positive sign of confidence in the company's future prospects.
• Employees participating in the Employee Stock Purchase Plan benefit from the opportunity to acquire company stock.

Key Dates

Keywords

Form 4, Bolt Biotherapeutics, William P. Quinn, Stock Options, Common Stock, Acquisition